(Q36572985)

15 August 2017

1 reference

title

Complement in lung disease (English)

1 reference

15 August 2017

3

Peter A Ward

1 reference

15 August 2017

2

Markus Huber-Lang

1 reference

15 August 2017

1

Vidya J Sarma

1 reference

15 August 2017

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

39

1 reference

15 August 2017

5

1 reference

15 August 2017

387-394

1 reference

Role of C5a in inflammatory responses

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Generation of C5a by phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

21 January 2018

Dampening inflammation

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Regulation of lung inflammation in the model of IgG immune-complex injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Requirement and role of C5a in acute lung inflammatory injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Stat3 activation in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Complement-induced impairment of innate immunity during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Elevated complement C3a in plasma from patients with severe acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

21 January 2018

New treatments for COPD.

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Mechanisms in COPD: differences from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

The C5a chemoattractant receptor mediates mucosal defence to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

C5a negatively regulates toll-like receptor 4-induced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

A role for the C3a anaphylatoxin receptor in the effector phase of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600739456

10.1080/08916930600739456

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16923538